Xin Lu

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert, Joseph K. Han, Martin Desrosiers et al. · The Lancet · 2019 · 1.5K citations

Medicine, Immunology, Otolaryngology +10

Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts

Surya P. Bhatt, Klaus F. Rabe, Nicola A. Hanania et al. · New England Journal of Medicine · 2023 · 458 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation

Surya P. Bhatt, Klaus F. Rabe, Nicola A. Hanania et al. · New England Journal of Medicine · 2024 · 245 citations

Life Sciences, Immunology, Pharmacotherapy +17

Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆

Xiaohua Wu, Jianqing Zhu, Rutie Yin et al. · Annals of Oncology · 2021 · 206 citations

Medicine, Oncology, Pharmacology +15

Shock tube study on ignition delay of hydrogen and evaluation of various kinetic models

Erjiang Hu, Lun Pan, Zhenhua Gao et al. · International Journal of Hydrogen Energy · 2016 · 76 citations

Natural Sciences, Nuclear Engineering, Chemical Kinetics +15